- Home
- RNAC vs MRBK Comparison
RNAC vs MRBK Comparison
Compare RNAC & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | MRBK |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.8M | 198.4M |
| IPO Year | 2016 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RNAC | MRBK |
|---|---|---|
| Price | $6.68 | $17.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $38.40 | $18.00 |
| AVG Volume (30 Days) | ★ 232.2K | 98.2K |
| Earning Date | 11-06-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | N/A | ★ 75.95 |
| EPS | N/A | ★ 1.77 |
| Revenue | $1,091,000.00 | ★ $109,758,000.00 |
| Revenue This Year | N/A | $26.84 |
| Revenue Next Year | N/A | $8.90 |
| P/E Ratio | ★ N/A | $9.97 |
| Revenue Growth | N/A | ★ 18.84 |
| 52 Week Low | $5.98 | $11.16 |
| 52 Week High | $20.12 | $18.33 |
Technical Indicators
Market Signals| Indicator | RNAC | MRBK |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 69.04 |
| Support Level | $6.40 | $17.40 |
| Resistance Level | $9.23 | $18.33 |
| Average True Range (ATR) | 0.69 | 0.34 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 12.01 | 64.90 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About MRBK Meridian Corporation
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.